Back to Directory

Sarah Bradford

Email

sbradford@fhi360.org

Phone

919-321-3673

Institution

FHI 360

Title

Senior Clinical Research Manager

Address

FHI360
359 Blackwell St
Ste 200
Durham, NC 27701
United States of America

Request an Update

Affiliated Studies

IMPAACT 2049: LEAP

DAIDS Number

Research Area

Study Status

IMPAACT 2024 : Phase I/II Dose Finding, Safety and Tolerability Study of Daily Rifapentine Combined with Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age with and without HIV

DAIDS Number

Research Area

Study Status

IMPAACT 2023: A Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

DAIDS Number

Research Area

Study Status

Closed to Follow Up

P1078: TB APPRISE: TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants

DAIDS Number

Research Area

P1101: Phase I/II Dose-Finding, Safety, Tolerance and Pharmacokinetics Study of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in HIV-infected and TB Co-infected Infants and Children

DAIDS Number

Research Area

Study Status

Show All